Opportunity Information: Apply for PAR 11 116
Apply for PAR 11 116
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Limited Competition Specific pathogen free macaque colonies (U42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351 Research Infrastructure Programs 93.389 National Center for Research Resources.
- This funding opportunity was created on Jan 9, 2014 and posted on Feb 14, 2011.
- Applicants must submit their applications by Jan 10, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition Specific Pathogen Free (SPF) Macaque Colonies (U42) funding opportunity (PAR-11-116) is a National Institutes of Health (NIH) cooperative agreement designed to continue supporting established SPF macaque breeding and holding colonies that were previously funded under an earlier NIH initiative (RFA RR-00-004). The central goal is to preserve and sustain a specialized nonhuman primate resource that directly supports AIDS and HIV-related research by ensuring access to macaques that are free of particular infectious agents. These animals are valuable because certain macaque viruses can interfere with immunology and virology study outcomes, complicate interpretation of experimental results, and in some cases increase occupational health risks for staff who handle the animals.
A key feature of the opportunity is that it is focused on continuity rather than launching brand-new colonies from scratch. Applicants are expected to demonstrate that they can keep existing SPF colonies operating at least at their current size and capability, which implies maintaining stable breeding, veterinary care, husbandry standards, and biosecurity practices that preserve SPF status over time. Because this is a cooperative agreement (U42), the NIH typically has a more involved role than in a standard grant, meaning awardees should be prepared for active coordination, reporting, and programmatic collaboration consistent with cooperative agreement mechanisms.
The announcement lays out several required operational elements that applicants must address in their proposals. First, they must provide a clear plan for maintaining SPF colonies at minimally current levels, which generally means sustaining infrastructure and procedures that prevent introduction and spread of excluded pathogens. Second, applicants must describe how they will distribute animals to AIDS researchers, and distribution must prioritize NIH-funded investigators first. This emphasis reflects the program’s role as a national research infrastructure resource rather than a colony intended primarily for local or internal institutional use. Third, applicants must outline how they will assay (test) animals for the presence of specific viruses, which is essential both to confirm SPF status and to provide researchers with confidence in the health background of animals used in sensitive infectious disease and immunology studies. Fourth, applicants must include plans for typing animals at specific major histocompatibility complex (MHC) loci. MHC typing is important because macaque immune genetics can strongly influence responses in vaccine studies, pathogenesis experiments, and immunological assays, and having typed animals improves study design and interpretability. Fifth, applicants must explain how they will finance colony operations, indicating that reviewers will look closely at financial sustainability, cost structure, and practical plans for covering ongoing operating expenses.
From an eligibility standpoint, the opportunity is broadly open to a range of organizational types, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits). The eligibility language also explicitly notes inclusion of several categories of institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian Serving Institutions, among others referenced in the “Additional Information on Eligibility” section of the full announcement. There is no cost sharing or matching requirement listed, which means applicants are not required to provide a formal non-federal match as a condition of award, though they still need to present a credible operational financing plan.
Administratively, this opportunity falls under NIH’s research infrastructure-related programming (CFDA 93.351 and 93.389 as listed in the source data). The posting date is noted as February 14, 2011, with related dates indicating the announcement lifecycle and an archive date of February 10, 2014. For full details, NIH directs applicants to the complete funding announcement at the NIH grants guide link (PAR-11-116). For access or technical issues with the online announcement, the listed point of contact is the NIH Office of Extramural Research (OER) Webmaster (FBOWebmaster@OD.NIH.GOV), which is meant for troubleshooting access and linking problems rather than scientific program questions.
In practical terms, the program is best understood as NIH maintaining a dependable pipeline of rigorously screened, genetically characterized macaques for HIV/AIDS research, with expectations that awardees will operate as resource centers. Successful applications would therefore be expected to show strong colony management capacity, robust pathogen surveillance and documentation, well-defined distribution policies that align with NIH priority rules, proven laboratory capability (or well-supported arrangements) for viral assays and MHC typing, and a realistic plan for long-term financial and operational stability.
Frequently Asked Questions (FAQs)
What is the Limited Competition Specific Pathogen Free (SPF) Macaque Colonies (U42) opportunity (PAR-11-116)?
PAR-11-116 is a National Institutes of Health (NIH) cooperative agreement (U42) intended to continue supporting established Specific Pathogen Free (SPF) macaque breeding and holding colonies. It is structured as a limited competition focused on sustaining colonies that were previously supported under an earlier NIH initiative (RFA RR-00-004).
What is the main purpose of this program?
The central purpose is to preserve and sustain a specialized nonhuman primate resource that supports AIDS and HIV-related research by ensuring access to macaques that are free of particular infectious agents. The program is designed to maintain a dependable pipeline of rigorously screened macaques for sensitive immunology and virology studies.
Why are SPF macaques important for AIDS/HIV research?
Some macaque viruses can interfere with immunology and virology study outcomes, complicate interpretation of experimental results, and in some cases increase occupational health risks for staff handling the animals. SPF macaques help reduce these confounding factors by providing animals with defined pathogen status.
Is this funding meant to create brand-new macaque colonies?
No. A defining feature of this opportunity is continuity. It is aimed at continuing support for established SPF macaque breeding and holding colonies rather than launching new colonies from scratch.
What does "limited competition" mean in the context of this opportunity?
Based on the description provided, the opportunity is intended for established SPF colonies that were previously funded under the earlier NIH initiative (RFA RR-00-004). The focus is on continuing those existing capabilities rather than broadly expanding to brand-new colony efforts.
What is a U42 cooperative agreement, and how does it differ from a typical grant?
A U42 is a cooperative agreement mechanism, which generally means NIH has a more involved role than with a standard grant. Awardees should expect active coordination, reporting, and programmatic collaboration consistent with cooperative agreement expectations.
What operational capabilities must applicants address in their proposals?
The announcement describes several required operational elements applicants should cover: (1) a plan to maintain SPF colonies at minimally current levels, (2) a process for distributing animals to AIDS researchers with NIH-funded investigators prioritized, (3) a plan to assay (test) animals for specific viruses to confirm SPF status, (4) plans for typing animals at specific major histocompatibility complex (MHC) loci, and (5) a clear approach for financing colony operations and demonstrating financial sustainability.
What does it mean to maintain colonies "at minimally current levels"?
It means applicants are expected to demonstrate they can keep existing SPF colonies operating at least at their current size and capability. This implies sustaining stable breeding, veterinary care, husbandry standards, and biosecurity practices needed to preserve SPF status over time.
Are awardees expected to distribute animals to researchers outside their own institution?
Yes. The program is described as a national research infrastructure resource rather than a colony intended primarily for local or internal institutional use. Applicants must describe how they will distribute animals to AIDS researchers, and distribution must prioritize NIH-funded investigators first.
Who must be prioritized when distributing SPF macaques?
Distribution must prioritize NIH-funded investigators first, according to the requirements described for the opportunity.
What testing or pathogen surveillance is required?
Applicants must outline how they will assay (test) animals for the presence of specific viruses. This testing is essential to confirm SPF status and to give researchers confidence in the health background of animals used in infectious disease and immunology studies.
Why does the opportunity require MHC typing?
The opportunity calls for typing animals at specific MHC loci because macaque immune genetics can strongly influence responses in vaccine studies, pathogenesis experiments, and immunological assays. Having MHC-typed animals improves study design and helps researchers interpret results.
Does the program require a financial sustainability plan?
Yes. Applicants must explain how they will finance colony operations. Reviewers are expected to look closely at financial sustainability, cost structure, and practical plans for covering ongoing operating expenses.
Is there a cost sharing or matching requirement?
No cost sharing or matching requirement is listed in the provided information. Applicants are not required to provide a formal non-federal match as a condition of award, but they still need to present a credible plan for financing ongoing operations.
What types of organizations are eligible to apply?
Eligibility is described as broad and includes public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits).
Are minority-serving institutions included in the eligible organization types?
Yes. The eligibility language explicitly notes inclusion of several categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian Serving Institutions, among others referenced in the full announcement's eligibility section.
What research area does this infrastructure primarily support?
The program is described as directly supporting AIDS and HIV-related research by providing access to SPF macaques suitable for immunology and virology studies.
How is the program positioned in terms of NIH priorities?
Based on the stated distribution requirements and infrastructure framing, awardees are expected to operate as resource centers serving the research community, with NIH-funded investigators receiving priority access to animals.
What CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA 93.351 and 93.389, as listed in the provided source data.
When was this funding opportunity posted, and when was it archived?
The posting date is listed as February 14, 2011. Related dates indicate the announcement lifecycle, and an archive date is noted as February 10, 2014.
Where can applicants find the full funding announcement details?
NIH directs applicants to the complete funding announcement in the NIH grants guide under PAR-11-116.
Who should be contacted for technical problems accessing the online announcement?
For access or technical issues with the online announcement, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV. This contact is intended for troubleshooting access and linking problems rather than scientific or programmatic questions.
What kind of operational strengths would a competitive application likely demonstrate?
Based on the requirements described, competitive applications would be expected to show strong colony management capacity, robust pathogen surveillance and documentation, well-defined distribution policies aligned with NIH priority rules, proven laboratory capability (or well-supported arrangements) for viral assays and MHC typing, and a realistic plan for long-term financial and operational stability.
Browse more opportunities from the same category: Education Health
Next opportunity: Limited Competition Specific pathogen free macaque colonies (U24)
Previous opportunity: Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza like Illness (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 116
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 116) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Specific pathogen free macaque colonies (U24) Apply for PAR 11 115 Funding Number: PAR 11 115 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS Implementation Science Targeting Drug Using Populations A Collaboration with PEPFAR (R01) Apply for RFA DA 12 002 Funding Number: RFA DA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Placebo Effect Mechanisms and Methodology (R21) Apply for RFA DA 12 004 Funding Number: RFA DA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Placebo Effect Mechanisms and Methodology (R01) Apply for RFA DA 12 003 Funding Number: RFA DA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Childhood Cancer Survivor Study (CCSS)(Limited Competition U24) Apply for RFA CA 11 501 Funding Number: RFA CA 11 501 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medication Initiative for Tobacco Dependence (MITD) A New Product Development Partnership (PDP)(UH2/UH3) Apply for RFA DA 11 015 Funding Number: RFA DA 11 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Centers in Minority Institutions Program (G12) Apply for PAR 11 132 Funding Number: PAR 11 132 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Institutional Training Grants for Research Training in Biomedical Informatics (T 15) Apply for RFA LM 11 001 Funding Number: RFA LM 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition National Primate Research Centers (P51) Apply for PAR 11 136 Funding Number: PAR 11 136 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 11 001 Funding Number: RFA EB 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 11 150 Funding Number: PAR 11 150 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 11 151 Funding Number: PAR 11 151 Agency: National Institutes of Health Category: Education Health Funding Amount: $680,000 |
| The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 11 152 Funding Number: PAR 11 152 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 11 156 Funding Number: PAR 11 156 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 11 146 Funding Number: PAR 11 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) Apply for RFA DA 12 006 Funding Number: RFA DA 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R01) Apply for PA 11 158 Funding Number: PA 11 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R21) Apply for PA 11 159 Funding Number: PA 11 159 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Apply for PA 11 160 Funding Number: PA 11 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Apply for PA 11 161 Funding Number: PA 11 161 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 116", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
